In a nationwide retrospective study of 30,491 Korean breast cancer patients, HER2-low breast cancer was characterized by a smaller tumor size, lower Ki-67 index, absence of LVI, but a higher HG when compared to HER2-0 breast cancer. This evidence concerns the gene MKI67 and breast cancer.